Managing Biosimilars Is Like Herding Copycats
Developers and Regulators Are Attending to Naming Conventions and Equivalence Testing Assays
The Scoop: St. Jude to Build a Collab-Fostering Research Hub
Ground Will Be Broken for a 625,000-Square-Foot Facility to Be Completed in 2021
Beyond Short Reads
Up-and-Coming Genomics Technologies Reveal Previously Unseen Structural Variants
Genomics Gets Personal
Despite Data and Privacy Challenges, Decreasing Cost Ushers in the Age of Personalized Whole-Genome Sequencing
Randi Hernandez ([email protected]) is managing editor of Genetic Engineering and Biotechnology News.
More GEN Content From This Contributor
- GEN News Highlights: Researchers Propose a Compounding Approach for the Manufacture of Biopharmaceuticals
- GEN News Highlights: Cell-Based Flu Vaccine Hits Commercial Scale
- GEN News Highlights: ACA Coverage Likely Facilitated Drug-Discovery Efforts
- GEN News Highlights: A Gene Fix for a Mouse Model of Duchenne?
- GEN News Highlights: CRISPR Corrects Disease Mutation in Human Embryos
- Columns: To Surge or Not to Surge?
- Feature Articles: Supplement: Integrated Continuous Manufacturing of Biologics
- GEN News Highlights: Genetic Turnover High at DNA “Hotspots”
- GEN News Highlights: Novel Continuous Cell Culture Method for Adherent Cells: Is it Useful?
- GEN News Highlights: In Excess of One Million: A Milestone in DNA Sequencing
- Feature Articles: Sequencing Within Reach
- Feature Articles: Sequencing Goes Long